HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise (CPSE) under the Ministry of Health & Family Welfare, has affirmed its financial dynamism by paying a record dividend of ₹69.53 crore to the Government of India for the fiscal year 2024–25, marking one of the highest-ever payouts in the company’s history. The dividend reflects HLL’s enhanced performance, accountability, and sustained contribution to India’s healthcare sector.
HLL: A Pillar of Affordable Healthcare
The dividend cheque was handed over to Union Health Minister Shri J.P. Nadda by Dr. Anitha Thampi, Chairperson, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare; Smt. Punya Salila Srivastava, Union Health Secretary; Shri Hovyeda Abbas, AS&FA; and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. Senior HLL officials, including Shri N. Ajit, Director (Marketing), and Shri Ramesh P, Director (Finance), participated in the ceremony.
Addressing the gathering, Shri J.P. Nadda described HLL as “a reliable hand in the field of medical services,” praising its pivotal role in realising the national vision of accessible, affordable, and quality healthcare. He highlighted that HLL and its subsidiaries, including Amrit Pharmacies, have transformed health service delivery, benefiting over 6.7 crore people and saving more than ₹8,000 crore in out-of-pocket expenses through affordable medicine initiatives.
Strong Financial Growth in FY 2024–25
In FY 2024–25, Company recorded substantial growth across both manufacturing and service operations. Revenue from operations reached ₹4,500 crore — an increase of 20% compared to the previous year. The company’s net worth rose sharply to ₹1,100 crore as of March 31, 2025. On a consolidated basis, including subsidiaries such as HITES, GAPL, and Lifespring Hospitals, the HLL Group achieved a total revenue of ₹4,900 crore, marking a 19% annual growth.
Minister Nadda observed that HLL’s consistent financial and social milestones make it a model enterprise balancing profitability with public welfare. Its integrated business model, leveraging manufacturing efficiency and social responsibility, supports national revenue generation and enhances access to healthcare for all citizens.
Legacy of Service and Innovation
Established on March 1, 1966, HLL Lifecare transitioned from addressing population control challenges to becoming a multi-product, multi-service healthcare innovator. Through projects like Amrit Pharmacies, HLL continues to ensure affordable access to essential drugs and medical products across India while pioneering initiatives in medical devices, diagnostics, and healthcare delivery. As the company celebrates its 60th year, it remains at the forefront of India’s public health ecosystem, poised for greater strides in equity, inclusion, and innovation.
Conclusion
By paying a record dividend and expanding its operations, HLL Lifecare Limited reaffirms its leadership as a responsible CPSE and trusted healthcare partner. Its consistent growth trajectory and impact-driven strategy illustrate the synergy between financial prudence and social purpose, aligning seamlessly with the government’s vision of accessible and affordable healthcare for all.
For more real-time updates, visit Channel 6 Network.
Source: PIB
